Supplementary Table 1 Prevalence of co-morbidities in younger-old (i.e., those aged between 65-74 years) patients with Alzheimer's disease or vascular dementia and corresponding dementia-free controls
Co-morbidities Alzheimer's disease Vascular dementia Cases Controls) OR (95% CI) Cases Controls OR (95% CI) (n = 1,305) (n = 1,306) (n = 598) (n = 600) n (%) n (%) n (%) n (%) n, number; OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
Supplementary Table 3 Prevalence of co-morbidities in the oldest-old (i.e., those aged 85+ years) patients with Alzheimer's disease or vascular dementia and corresponding dementia-free controls n, number; OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
Supplementary Table 4 Exposure prevalence to various drugs in younger-old (i.e., those aged between 65-74 years) patients with Alzheimer's disease or vascular dementia and corresponding dementia-free controls n, number; OR, odds ratio; CI, confidence interval; ACE, angiotensin-converting enzyme; AT, angiotensin; NSAIDs, nonsteroidal anti-inflammatory drugs.
Supplementary Table 5 Exposure prevalence to various drugs in patients older-old (i.e., those aged between 75-84 years) with Alzheimer's disease or vascular dementia and corresponding dementia-free controls
Drugs
Alzheimer's disease n, number; OR, odds ratio; CI, confidence interval; ACE, angiotensin-converting enzyme; AT, angiotensin; NSAIDs, nonsteroidal anti-inflammatory drugs.
Supplementary Table 6 Exposure prevalence to various drugs in patients the oldest-old (i.e., those aged 85+ n, number; OR, odds ratio; CI, confidence interval; ACE, angiotensin-converting enzyme; AT, angiotensin; NSAIDs, nonsteroidal anti-inflammatory drugs.
